Skip to main content
SpringerLink
Log in

Harbingers of hypertrophy and heart failure

  • Clinical Implications
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Wilkins BJ, Molkentin JD (2002) Calcineurin and cardiac hypertrophy: where have we been? Where are we going? J Physiol (Lond) 541:1–8

    Google Scholar 

  2. Frey N, Olson EN (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65:45–79

    Article  CAS  PubMed  Google Scholar 

  3. Diedrichs H, Mei C, Frank KF, Boelck B, Schwinger RHG (2004) Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene TGR (mREN2)27. J Mol Med (http://dx.doi.org/10.1007/s00109-004-581-9)

  4. Boer RA de, Pokharel S, Flesch M, Kampen DA van, Suurmeijer AJH, Boomsma F, Gilst WH van, Veldhuisen DJ van, Pinto YM (2004) Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR (mRen2)27. J Mol Med (http://dx.doi.org/10.1007/s00109-004-579-3)

  5. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215–228

    Article  CAS  PubMed  Google Scholar 

  6. Finckenberg P, Inkinen K, Ahonen J, Merasto S, Louhelainen M, Vapaatalo H, Muller D, Ganten D, Luft F, Mervaala E (2003) Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways. Am J Pathol 163:355–366

    CAS  PubMed  Google Scholar 

  7. Bueno OF, Molkentin JD (2002) Involvement of extracellular signal-related kinases 1/2 in cardiac hypertrophy and cell death. Circ Res 91:776–781

    Article  CAS  PubMed  Google Scholar 

  8. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, Hewett TE, Jones SP, Lefer DJ, Peng CF, Kitsis RN, Molkentin JD (2000) The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 19:6341–6350

    Article  CAS  PubMed  Google Scholar 

  9. Kagiyama S, Eguchi S, Frank GD, Inagami T, Zhang YC, Phillips MI. Related Articles, Links Abstract Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense. Circulation 106:909–912

  10. Mazak I, Fiebeler A, Muller DN, Park JK, Shagdarsuren E, Lindschau C, Dechend R, Viedt C, Pilz B, Haller H, Luft FC (2004) Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation 109:2792–2800

    Article  CAS  PubMed  Google Scholar 

  11. Bassel-Duby R, Olson EN (2004) Role of calcineurin in striated muscle: development, adaptation, and disease. Biochem Biophys Res Commun 311:1133–1141

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Franz Vollhard Clinic, Helios Klinikum Berlin, Medical Faculty of the Charité, Humboldt University of Berlin, Wiltbergstrasse 50, 13125, Berlin-Buch, Germany

    Friedrich C. Luft

Authors
  1. Friedrich C. Luft
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Friedrich C. Luft.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luft, F.C. Harbingers of hypertrophy and heart failure. J Mol Med 82, 635–637 (2004). https://doi.org/10.1007/s00109-004-0577-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-004-0577-5

Search

Navigation